Abstract
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of conditions collectively known as myositis, characterized most frequently by muscle weakness and muscle inflammation. They are further classified into dermatomyositis, polymyositis, immune-mediated necrotizing myositis, inclusion body myositis, juvenile dermatomyositis, and overlap myositis.1 The increased risk of cancer in patients with myositis, particularly dermatomyositis, is widely recognized, and myositis with a diagnosis of cancer within 3 years is termed cancer-associated myositis (CAM).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
